Ensifentrine
CAS No : 1902955-29-6
General description:
Ensifentrine is an active pharmaceutical ingredient (API) under development for the treatment of chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma. It is a dual phosphodiesterase (PDE) 3 and PDE4 inhibitor, designed to provide both bronchodilatory and anti-inflammatory effects in the respiratory system.
Ensifentrine is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the development of advanced inhalation and respiratory therapies.
Ensifentrine is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the development of advanced inhalation and respiratory therapies.
Chemical Structure:
